A therapeutic and epitome resource for Human Papillomaviruses
Efficient putative sgRNAs (CRISPR/Cas9 targets)
S.No. |
HPV type |
Target region |
sgRNA seuences |
PAM |
Strand(F/R) |
Start |
End |
GC (%) |
Predicted effeciency (%) |
1 |
HPV16 |
E5 | GTAGACACAGACAAAAGCAG | CGG |
R |
140 |
159 |
45 |
75.42 |
2 |
HPV16 |
E5 | AATAAAACACCTAAACGCAG | AGG |
R |
70 |
89 |
35 |
44.85 |
3 |
HPV18 |
E5 | ATACAGACAGATGGCAAAAG | CGG |
R |
140 |
159 |
40 |
41.24 |
4 |
HPV35 |
E5 | TGAGCGTTAATCATTCCCAT | AGG |
R |
26 |
45 |
40 |
58.28 |
5 |
HPV39 |
E5 | CAGTCTATGCAACAACCACA | TGG |
R |
19 |
38 |
45 |
56.36 |
6 |
HPV45 |
E5 | GGACATTGCAGCACACATAA | AGG |
R |
162 |
181 |
45 |
46.72 |
7 |
HPV52 |
E5 | TGACAGTGAATACAAAACAT | TGG |
R |
29 |
48 |
30 |
43.32 |
8 |
HPV58 |
E5 | ATAGAAATAGATAGCACCAA | TGG |
R |
146 |
165 |
30 |
49.35 |
9 |
HPV73 |
E5 | TAATCAATACCAATAACCAT | GGG |
R |
117 |
136 |
25 |
45.47 |
10 |
HPV73 |
E5 | ATAATCAATACCAATAACCA | TGG |
R |
116 |
135 |
25 |
44.53 |